999 Omeprazole and Sodium Bicarbonate Capsules

1. Indications and Usage
Symptomatic Relief: Used for the rapid relief of gastric pain, heartburn, and acid reflux caused by excessive gastric acid.
Peptic Ulcer Disease: Treatment of active duodenal and gastric ulcers.
Reflux Esophagitis: Management of gastroesophageal reflux disease (GERD) and erosive esophagitis.
2. Dosage and Administration
Adults: Oral administration. The usual dosage is 1 capsule twice daily (morning and evening), or as directed by a physician.
Timing: Should be taken before meals.
Duration:
Symptomatic Relief: Continuous use should not exceed 2 weeks.
Peptic Ulcer/GERD: Typically treated for 4 to 8 weeks.
Special Populations: Dosage adjustment may be required for patients with hepatic or renal impairment.
3. Mechanism of Action
Proton Pump Inhibition: Omeprazole is a proton pump inhibitor (PPI) that selectively inhibits the H+/K+-ATPase enzyme in gastric parietal cells, blocking the final step of acid production.
Antacid Effect: Sodium bicarbonate acts as a rapid antacid, neutralizing existing gastric acid and providing immediate symptom relief while omeprazole takes effect.
4. Safety and Warnings
Gastric Malignancy: Symptoms of gastric ulcer may resemble those of gastric carcinoma; malignancy should be ruled out before treatment.
Long-term Use: Prolonged use of PPIs may lead to hypomagnesemia, vitamin B12 deficiency, and increased risk of bone fractures.
Hypersensitivity: Contraindicated in patients with a history of hypersensitivity to omeprazole, other benzimidazoles, or sodium bicarbonate.
Special Populations: Use with caution in patients with hepatic dysfunction.
5. Adverse Reactions and Clinical Research
Common Adverse Reactions: Diarrhea, abdominal pain, nausea, headache, and dizziness.
Rare Adverse Reactions: Elevated liver enzymes, hypomagnesemia, leukopenia, thrombocytopenia, and hypersensitivity reactions (e.g., rash, angioedema).
Clinical Efficacy: Clinical studies demonstrate that the combination provides faster symptom relief compared to omeprazole alone and is highly effective in healing ulcers.
6. Drug Interactions
pH-Dependent Drugs: May decrease the absorption of drugs requiring an acidic environment (e.g., ketoconazole, itraconazole, atazanavir, erlotinib).
Clopidogrel: Omeprazole may reduce the antiplatelet efficacy of clopidogrel.
Methotrexate: High-dose methotrexate toxicity may be increased due to reduced renal clearance.
7. Pharmaceutical Information
Active Ingredients: Omeprazole and Sodium Bicarbonate.
Appearance: Hard gelatin capsules, typically containing white or yellowish granules or powder.
Storage: Store in a tight, light-resistant container at controlled room temperature. Protect from moisture.